5
Participants
Start Date
November 10, 2017
Primary Completion Date
September 3, 2019
Study Completion Date
October 27, 2019
nintedanib
Oral nintedanib, taken twice daily
Levine Cancer Institute, Charlotte
Collaborators (1)
Boehringer Ingelheim
INDUSTRY
Wake Forest University Health Sciences
OTHER